BIVRX vs. UPRO
Compare and contrast key facts about Invenomic Fund (BIVRX) and ProShares UltraPro S&P 500 (UPRO).
BIVRX is managed by Invenomic. It was launched on Jun 18, 2017. UPRO is a passively managed fund by ProShares that tracks the performance of the S&P 500 Index (300%). It was launched on Jun 23, 2009.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: BIVRX or UPRO.
Performance
BIVRX vs. UPRO - Performance Comparison
Returns By Period
In the year-to-date period, BIVRX achieves a -12.32% return, which is significantly lower than UPRO's 72.86% return.
BIVRX
-12.32%
0.47%
-3.14%
-24.42%
8.57%
N/A
UPRO
72.86%
7.77%
32.64%
96.42%
25.23%
24.24%
Key characteristics
| BIVRX | UPRO | |
|---|---|---|
| Sharpe Ratio | -1.32 | 2.65 |
| Sortino Ratio | -1.57 | 3.02 |
| Omega Ratio | 0.72 | 1.41 |
| Calmar Ratio | -0.71 | 2.57 |
| Martin Ratio | -1.11 | 15.86 |
| Ulcer Index | 22.06% | 6.08% |
| Daily Std Dev | 18.53% | 36.39% |
| Max Drawdown | -34.31% | -76.82% |
| Current Drawdown | -32.72% | -2.13% |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
BIVRX vs. UPRO - Expense Ratio Comparison
BIVRX has a 2.48% expense ratio, which is higher than UPRO's 0.92% expense ratio.
Correlation
The correlation between BIVRX and UPRO is 0.07, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Risk-Adjusted Performance
BIVRX vs. UPRO - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Invenomic Fund (BIVRX) and ProShares UltraPro S&P 500 (UPRO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
BIVRX vs. UPRO - Dividend Comparison
BIVRX's dividend yield for the trailing twelve months is around 2.99%, more than UPRO's 0.73% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BIVRX Invenomic Fund | 2.99% | 2.62% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
UPRO ProShares UltraPro S&P 500 | 0.73% | 0.74% | 0.52% | 0.06% | 0.11% | 0.53% | 0.63% | 0.00% | 0.12% | 0.34% | 0.22% | 0.07% |
Drawdowns
BIVRX vs. UPRO - Drawdown Comparison
The maximum BIVRX drawdown since its inception was -34.31%, smaller than the maximum UPRO drawdown of -76.82%. Use the drawdown chart below to compare losses from any high point for BIVRX and UPRO. For additional features, visit the drawdowns tool.
Volatility
BIVRX vs. UPRO - Volatility Comparison
The current volatility for Invenomic Fund (BIVRX) is 2.96%, while ProShares UltraPro S&P 500 (UPRO) has a volatility of 11.99%. This indicates that BIVRX experiences smaller price fluctuations and is considered to be less risky than UPRO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.